A pilot window-of-opportunity study of preoperative fluvastatin in localized prostate cancer

BACKGROUND: Statins inhibit HMG-CoA reductase, the rate-limiting enzyme of the mevalonate pathway. Epidemiological and pre-clinical evidence support an association between statin use and delayed prostate cancer (PCa) progression. Here, we evaluated the effects of neoadjuvant fluvastatin treatment on...

Descripción completa

Detalles Bibliográficos
Autores principales: Longo, Joseph, Hamilton, Robert J., Masoomian, Mehdi, Khurram, Najia, Branchard, Emily, Mullen, Peter J., Elbaz, Mohamad, Hersey, Karen, Chadwick, Dianne, Ghai, Sangeet, Andrews, David W., Chen, Eric X., van der Kwast, Theodorus H., Fleshner, Neil E., Penn, Linda Z.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7655503/
https://www.ncbi.nlm.nih.gov/pubmed/32203069
http://dx.doi.org/10.1038/s41391-020-0221-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7655503/
https://www.ncbi.nlm.nih.gov/pubmed/32203069
http://dx.doi.org/10.1038/s41391-020-0221-7

Ejemplares similares